| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C8H17NO5
|
|---|
| Exact mass |
207.1107
|
|---|
| Mol weight |
207.22
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BF Alpha glucosidase inhibitors
A10BF02 Miglitol
D00625 Miglitol (JP18/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Antidiabetic Agents
Glucose Control Agents, Other
Miglitol
D00625 Miglitol (JP18/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
396 Antidiabetic agents
3969 Others
D00625 Miglitol (JP18/USAN/INN)
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01663 alpha-Glucosidase inhibitor
D00625 Miglitol
Drug classes [BR:br08332]
Antidiabetic agent
DG01663 alpha-Glucosidase inhibitor
D00625 Miglitol
DG02044 Hypoglycemic agent
D00625 Miglitol
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Glycosidases
GAA
D00625 Miglitol (JP18/USAN/INN) <JP/US>
GANC
D00625 Miglitol (JP18/USAN/INN) <JP/US>
MGAM
D00625 Miglitol (JP18/USAN/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00625 Miglitol
D00625 Miglitol tablets
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00625
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 14
1 N1y N 25.6615 -16.6519
2 C1y C 24.4566 -17.3596
3 C1x C 26.8780 -17.3304
4 C1b C 25.7022 -15.2482
5 C1y C 24.4042 -18.7692
6 C1b C 23.2342 -16.6753
7 C1y C 26.8957 -18.7282
8 C1b C 26.8429 -14.5346
9 C1y C 25.6967 -19.4477
10 O1a O 23.2693 -19.4769
11 O1a O 22.0352 -17.3889
12 O1a O 28.1181 -19.4126
13 O1a O 26.8254 -13.1309
14 O1a O 25.7084 -20.8455
BOND 14
1 1 2 1
2 1 3 1
3 1 4 1 #Up
4 2 5 1
5 2 6 1 #Up
6 3 7 1
7 4 8 1
8 5 9 1
9 5 10 1 #Down
10 6 11 1
11 7 12 1 #Down
12 8 13 1
13 9 14 1 #Up
14 7 9 1
|
|---|
